You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

Article metrics

Article menu
Original research
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

AbstractFullPdf
Aug 202135334181
Sep 2021536527173
Oct 2021277272105
Nov 2021465449112
Dec 202138838397
Jan 202234532296
Feb 2022396377127
Mar 2022466450163
Apr 2022452438120
May 2022436408140
Jun 202231231189
Jul 202231229692
Aug 2022348346137
Sep 2022350339118
Oct 2022343326110
Nov 2022245233121
Dec 202215814174
Jan 202314313784
Feb 2023276254136
Mar 2023312287144
Apr 2023226220121
May 2023241229106
Jun 202324022881
Jul 202320919984
Aug 2023219202106
Sep 202320119191
Oct 2023226208112
Nov 202326124598
Dec 2023275234124
Jan 2024295220135
Feb 2024216186117
Mar 2024346318253
Total986893173747